Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May 27;14(6):1160.
doi: 10.3390/v14061160.

Novel Vaccines and Drugs That Target the Surface Glycoproteins of Influenza Viruses, RSV, Parainfluenza Viruses, and SARS-CoV-2

Charles J Russell  1 , Elena A Govorkova  1
Affiliations
Editorial

Novel Vaccines and Drugs That Target the Surface Glycoproteins of Influenza Viruses, RSV, Parainfluenza Viruses, and SARS-CoV-2

Charles J Russell et al. Viruses. .

Abstract

Newly emerging and seasonal respiratory viruses have a great impact on public health[...]

PubMed Disclaimer

Conflict of interest statement

C.J.R. has received NIH/NIAID research grant R01AI083370 in part to develop the Sendai virus vector. The work completed in the studies and the views expressed here do not necessarily represent the official views of the National Institutes of Health. C.J.R. is a co-inventor of patent US2014/0186397, Modified SeV vaccine and imaging vector (3 July 2014).

Similar articles

See all similar articles

References

    1. Narkhede Y.B., Gonzalez K.J., Strauch E.M. Targeting Viral Surface Proteins through Structure-Based Design. Viruses. 2021;13:1320. doi: 10.3390/v13071320. - DOI - PMC - PubMed
    1. Tripp R.A., Stambas J. Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins. Viruses. 2021;13:625. doi: 10.3390/v13040625. - DOI - PMC - PubMed
    1. Nagashima K.A., Mousa J.J. Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine. Viruses. 2021;13:546. doi: 10.3390/v13040546. - DOI - PMC - PubMed
    1. Wiggins K.B., Smith M.A., Schultz-Cherry S. The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations. Viruses. 2021;13:1109. doi: 10.3390/v13061109. - DOI - PMC - PubMed
    1. Vajo Z., Balaton G., Vajo P., Torzsa P. A Reduced Dose Whole Virion Aluminum Adjuvanted Seasonal Influenza Vaccine Is Immunogenic, Safe, and Well Tolerated in Pediatric Patients. Viruses. 2021;13:500. doi: 10.3390/v13030500. - DOI - PMC - PubMed

Publication types